Kimia Farma (Persero) Overview
- Year Founded
-
1816
- Status
-
Public
- Employees
-
10,712
- Stock Symbol
-
KAEF
- Investments
-
2
- Share Price
-
$0.02
- (As of Monday Closing)
Kimia Farma (Persero) General Information
Description
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.
Contact Information
Website
www.kimiafarma.co.idCorporate Office
- PO Box 1204
- Jakarta, 10110
- Indonesia
Corporate Office
- PO Box 1204
- Jakarta, 10110
- Indonesia
Kimia Farma (Persero) Stock Performance
As of 24-Mar-2025, Kimia Farma (Persero)’s stock price is $0.02. Its current market cap is $116M with 5.57B shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.02 | $0.02 | $0.02 - $0.07 | $116M | 5.57B | 1.82M | -$0.02 |
Kimia Farma (Persero) Financials Summary
As of 30-Sep-2024, Kimia Farma (Persero) has a trailing 12-month revenue of $639M.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 766,504 | 1,070,278 | 926,110 | 1,483,332 |
| Revenue | 638,953 | 653,198 | 621,054 | 895,264 |
| EBITDA | (105,175) | (68,832) | 67,512 | 102,280 |
| Net Income | (109,295) | (97,377) | (12,813) | 21,047 |
| Total Assets | 1,110,383 | 1,126,180 | 1,272,493 | 1,204,934 |
| Total Debt | 500,502 | 493,181 | 521,531 | 561,323 |
Kimia Farma (Persero) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kimia Farma (Persero) Comparisons
Industry
Financing
Details
Kimia Farma (Persero) Competitors (4)
One of Kimia Farma (Persero)’s 4 competitors is Tempo Scan Pacific, a Corporation company based in Jakarta, Indonesia.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Tempo Scan Pacific | Corporation | Jakarta, Indonesia | ||||
| Cipla | Corporation | Mumbai, India | ||||
| Kalbe Farma | Corporation | Jakarta, Indonesia | ||||
| Procter & Gamble Hygiene and Health Care | Corporation | Mumbai, India |
Kimia Farma (Persero) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Kimia Farma (Persero) Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kimia Farma (Persero) Acquisitions (2)
Kimia Farma (Persero)’s most recent deal was a Merger/Acquisition with Al Dawaa Medical Services for . The deal was made on 05-Mar-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Al Dawaa Medical Services | 05-Mar-2018 | Merger/Acquisition | Distributors (Healthcare) | ||
| Mandiri Inhealth | 02-May-2014 | Merger/Acquisition | Life and Health Insurance |
Kimia Farma (Persero) ESG
Risk Overview
Risk Rating
Updated October, 17, 2024
37.77 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,946
Rank
Percentile
Pharmaceuticals
Industry
of 847
Rank
Percentile
Pharmaceuticals
Subindustry
of 421
Rank
Percentile
Kimia Farma (Persero) Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Al Dawaa Medical Services | Khobar, Saudi Arabia | 1994 |
Kimia Farma (Persero) FAQs
-
When was Kimia Farma (Persero) founded?
Kimia Farma (Persero) was founded in 1816.
-
Where is Kimia Farma (Persero) headquartered?
Kimia Farma (Persero) is headquartered in Jakarta, Indonesia.
-
What is the size of Kimia Farma (Persero)?
Kimia Farma (Persero) has 10,712 total employees.
-
What industry is Kimia Farma (Persero) in?
Kimia Farma (Persero)’s primary industry is Drug Discovery.
-
Is Kimia Farma (Persero) a private or public company?
Kimia Farma (Persero) is a Public company.
-
What is Kimia Farma (Persero)’s stock symbol?
The ticker symbol for Kimia Farma (Persero) is KAEF.
-
What is the current stock price of Kimia Farma (Persero)?
As of 24-Mar-2025 the stock price of Kimia Farma (Persero) is $0.02.
-
What is the current market cap of Kimia Farma (Persero)?
The current market capitalization of Kimia Farma (Persero) is $116M.
-
What is Kimia Farma (Persero)’s current revenue?
The trailing twelve month revenue for Kimia Farma (Persero) is $639M.
-
Who are Kimia Farma (Persero)’s competitors?
Tempo Scan Pacific, Cipla, Kalbe Farma, and Procter & Gamble Hygiene and Health Care are competitors of Kimia Farma (Persero).
-
What is Kimia Farma (Persero)’s annual earnings per share (EPS)?
Kimia Farma (Persero)’s EPS for 12 months was -$0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
